With the analysis among 6,317 patents, we discovered top 464 key players by total patent application. Novartis AG, F. Hoffmann-La Roche Ltd., Eli Lilly & Co. are dominant in this area. They take 8.03% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 205
F. Hoffmann-La Roche Ltd.
Indiana, United States
Patent: 133
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 117
Antwerpen, Belgium
Patent: 113
California, United States
Patent: 90
New York, United States
Patent: 82
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 82
California, United States
Patent: 80
New York, United States
Patent: 73
With the analysis among 191 patents, we discovered top 44 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Mitochon Pharmaceuticals, Inc., HepaRegeniX GmbH are active in this area.
Institut National de la Santé et de la Recherche Médicale
Mitochon Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 21
Baden-Württemberg, Germany
Patent: 19
Utrecht, Netherlands
Patent: 16
Texas, United States
Patent: 10
Texas, United States
Patent: 8
Carrick Therapeutics Ltd.
Aardvark Therapeutics, Inc.
California, United States
Patent: 7
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 5
With the analysis among related 2,786 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Eli Lilly & Co., Regeneron Pharmaceuticals, Inc., China Pharmaceutical University take 6.21% of patent filing during this period.
Indiana, United States
Patent: 78
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 64
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 31
Illinois, United States
Patent: 28
Basel-Stadt, Switzerland
Patent: 27
Antwerpen, Belgium
Patent: 25
Nordrhein-Westfalen, Germany
Patent: 24
Baden-Württemberg, Germany
Patent: 19
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 19
With the analysis among related 2,786 patents in last 5 years, we discover 336 new entrants. MeiraGTx UK II Ltd., Ruprecht-Karls-Universität Heidelberg, HepaRegeniX GmbH are the most active new entrants in this area.
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 19
Baden-Württemberg, Germany
Patent: 19
Utrecht, Netherlands
Patent: 16
Crystal Pharmaceutical (Suzhou) Co., Ltd
Jiangsu Sheng, China
Patent: 16
Virginia, United States
Patent: 15
With the analysis among 1,221 patents, we discovered top 243 universities and scientific research institutions by total patent application. China Pharmaceutical University, Ruprecht-Karls-Universität Heidelberg, Queen Mary University of London are dominant in this area. They take 8.03% of the total patent filing.
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 32
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 19
Queen Mary University of London
President & Fellows of Harvard College
Massachusetts, United States
Patent: 18
Jiangsu Sheng, China
Patent: 12
National University of Singapore
Central Region, Singapore
Patent: 10
Baylor College of Medicine
Texas, United States
Patent: 10
Chinese Academy of Medical Scciences & Peking Union Medical College
Charité - Universitätsmedizin Berlin
Université d'Aix-Marseille